Volume 2, Issue 3 (2017)                   SJMR 2017, 2(3): 187-190 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shafeghati Y. HELLP Syndrome, Acute Fatty Liver of Pregnancy, and Fatty Acids Oxidation Defects. SJMR 2017; 2 (3) :187-190
URL: http://saremjrm.com/article-1-57-en.html
”Sarem Fertility and Infertility Research Center (SAFIR)” and “Sarem Cell Research Center (SCRC)”, Sarem Women’s Hospital, Tehran, Iran , yshafagh@gmail.com
Abstract:   (14087 Views)

Patient Information: Hemolysis, Elevated Liver enzymes, and Low Platelet count (HELLP) syndrome is one of the common and important complications of pregnancy. Also, Acute Fatty Acid Liver of Pregnancy (AFLP) is a very severe and less common complication in pregnancy with high mortality rate. In Fatty Acids Oxidation Defects (FAODs), patients cannot metabolize fatty acids. Asymptomatic carrier mothers are at higher risk for one of these diseases. A 33-year-old pregnant woman at the 22nd week of pregnancy with a 2-day history of abdominal pain, headache, blurred vision, and vomiting was referred to the hospital emergency room and hospitalized there. The patient was an agitated at the time of admission. She was worked up with the impairment of sensation, jaundice, high blood pressure, and proteinuria with the suspicion of HELLP syndrome. The patient had high LDH, high SGOT levels, and very low platelets, and despite the onset of medical and preventive measures, the embryo was aborted 24 hours later. In later maternal assessments, a genetic-metabolic disorder was diagnosed from the group of oxidation disorders of fatty acids.
Conclusion: FAODs in mitochondria are a group of genetic and metabolic diseases that are transmitted through the autosomal recessive inheritance pattern. These disorders in mothers who are heterozygous for this disease have important side effects such as severe preeclampsia, AFLP, and HELLP syndrome. These diseases are relatively common and should be taken into account in pregnancies at risk.

Full-Text [PDF 366 kb]   (1996 Downloads) |   |   Full-Text (HTML)  (1196 Views)  
Article Type: Case Report | Subject: Sterility
Received: 2016/04/13 | Accepted: 2016/09/20 | Published: 2017/11/16

References
1. 1- Pritchard Ja, Weisman R Jr, Ratnoff Od, Vosburgh Gj. Intravascular hemolysis, thrombocytopenia and other hematologic abnormalities associated with severe toxemia of pregnancy. N Engl J Med. 1954;250(3):89-98. [Link] [DOI:10.1056/NEJM195401212500301] [PMID]
2. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: A severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982;142(2):159-67. [Link] [DOI:10.1016/S0002-9378(16)32330-4]
3. Weinstein L. It has been a great ride: The history of HELLP syndrome. Am J Obstet Gynecol. 2005;193(3 Pt 1):860-3. [Link] [DOI:10.1016/j.ajog.2005.06.058] [PMID]
4. Audibert F, Friedman SA, Frangieh AY, Sibai BM. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol. 1996;175(2):460-4. [Link] [DOI:10.1016/S0002-9378(96)70162-X]
5. Barton JR, Sibai BM. Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol. 2004;31(4):807-33. [Link] [DOI:10.1016/j.clp.2004.06.008] [PMID]
6. Martin JN Jr, Rose CH, Briery CM. Understanding and managing HELLP syndrome: The integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol. 2006;195(4):914-34. [Link] [DOI:10.1016/j.ajog.2005.08.044] [PMID]
7. Chauhan SP, Sanderson M, Hendrix NW, Magann EF, Devoe LD. Perinatal outcome and amniotic fluid index in the antepartum and intrapartum periods: A meta-analysis. Am J Obstet Gynecol. 1999;181(6):1473-8. [Link] [DOI:10.1016/S0002-9378(99)70393-5]
8. Publications Committee, Society for Maternal-Fetal Medicine, Sibai BM. Evaluation and management of severe preeclampsia before 34 weeks' gestation. Am J Obstet Gynecol. 2011;205(3):191-8. [Link] [DOI:10.1016/j.ajog.2011.07.017] [PMID]
9. Shafeghati Y, Sarkheil P. Metabolic disorders clinical and molecular Persian. Tehran: Sarem Book; 2014. pp. 109-208. [Persian] [Link]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | {Sarem Journal of Medical Research}

Designed & Developed by : Yektaweb